TECH SUPPLIER Nov 2022 - Market Analysis Perspective - Doc # EUR149804422
Worldwide Medical Devices, 2022
This IDC Market Analysis Perspective examines the worldwide medical devices market. It delivers a concise view of the current state of the market and its digital transformation trends, provides an overview of the ecosystem of players, and offers insights into the impact of future trends. Medical device organizations' IT executives and their IT vendors can use this information to understand key industry impacts to seize market opportunities.
"The value chains of medical devices companies are rapidly changing to support the evolution toward integrated and personalized healthcare models and the adoption of innovative and complex approaches such as precision medicine. At the same time, medical devices companies will need to help healthcare organizations to lower costs and become more resilient. This requires creating value beyond the device that can be achieved only by adopting new, digitally enabled business and operating models," said Silvia Piai, research director, IDC Health Insights. "Forward-looking technology companies will leverage their digital strategies also to adapt to the fast-evolving regulatory landscape worldwide, which includes new ESG, quality, and safety requirements," said Nino Giguashvili, research manager, IDC Health Insights. "Moreover, looking beyond traditional B2B markets, digitally enabled value propositions will be a precondition to seize new opportunities offered by healthcare consumerization and the new B2C play," said Federico Mayr, research analyst, IDC Health Insights.
IDC Health Insights: Worldwide Medical Device Digital Strategies
CERIBELL, INC., Oracle Corporation, NVIDIA Corporation, Atos SE, THERAPIXEL, Google LLC, Veeva Systems Inc., DistalMotion SA, Closed Loop Medicine Ltd, Amazon Web Services Inc., Akili Interactive Labs Inc., Nutromics Pty Ltd, Infosys Limited
Cloud-based partners, Engineering applications
- 23 slides
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.